Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Published

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Scientific reports
Date: 2017-10-13
Source: PubMed
DOI: 10.1038/s41598-017-13282-7
PubMed: 29030624

Authors

Carhart-Harris RL Roseman L Bolstridge M Demetriou L Pannekoek JN Wall MB Tanner M Kaelen M McGonigle J Murphy K Leech R Curran HV Nutt DJ

Watch author

Derived topics and classifications

psilocybin Depression Brain Imaging Mechanism of Action Receptor Pharmacology Default Mode Network Aging Treatment-Resistant Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 14 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review2026-09-10 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Human brain changes after first psilocybin use2026-05-05 Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Explainable AI framework for psilocybin depression treatment optimization2026-03-16 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review2026-03-09 Acute psilocin increased cortical activity in rat2026-02-04 Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds2025-09-30 Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications2025-03-07 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01 Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.2017-10-13

Related papers

Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-10-02 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older AdultsClinicalTrials.gov · 2025-10-21 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDDClinicalTrials.gov · 2024-01-24 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17